# BridgeBio Pharma, Inc.: Form 8-K, filed Jan 26, 2021

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 8-K
- Filed: 2021-01-26
- Accepted by EDGAR: Jan 26, 2021, 08:46 ET
- Period: 2021-01-26
- Accession: 0001193125-21-017108
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312521017108/d52744d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312521017108/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312521017108/d52744d8k.htm

Filed Jan 26, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-017108. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
